tissue factor gene therapy (Merckle)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametissue factor gene therapy (Merckle)
Drug Alias Namediabetic ulcer therapy (Merckle)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionTissue factor modulators
TargetsTissue factor
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerckle Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerckle Gmbh
Active IndicationsN/A
Inactive IndicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A